Whether you’re organization is a biotech startup, a pharmaceutical manufacturer, or an academic research institution, the decision to store samples in-house or to outsource to a dedicated biostorage or biorepository facility is critical. At first glance, the prospect of owning and operating freezers may seem like a straightforward solution. However, the true cost of ownership encompasses far more than the initial purchase price. A life science company seeking to acquire biosample storage capacity should understand the total cost and long-term implications of this decision.
In-house Biosample Storage
Many biopharma companies view immediate access to samples, reduced logistics, and streamlined lab operations as reasons to maintain in-house storage. Some storage situations may justify the expense and maintenance requirements of internal capacity. But for organizations with infrequent access requirements, large-scale storage needs, long-term archiving, or critical sample integrity concerns, outsourcing typically provides a more reliable, cost-effective, and risk-mitigated solution. The decision ultimately depends on your operational capabilities and financial considerations.
When considering in-house biorepository organizations often focus on the upfront cost of purchasing freezers. However, the complete cost of ownership of tissue banks, DNA storage, or laboratory sample storage extends beyond the capital expense and encompasses many overlooked outlays.
1. Equipment Costs
High-quality Ultra-Low Temperature (ULT) freezers can cost anywhere from $10,000 to $25,000 per unit. A research facility or pharmaceutical company requiring multiple units will quickly see capital expenditure rise into the hundreds of thousands. These freezers have a lifespan of approximately 10–15 years, necessitating periodic replacements that contribute to long-term costs.
2. Validation and Compliance
Regulatory compliance is a non-negotiable part of the biorepository setup. Each freezer must undergo rigorous validation to meet Good Manufacturing Practice (GMP) standards, as well as those of the FDA and other relevant industry standards. This process includes:
- Installation qualification (IQ)
- Operational qualification (OQ)
- Performance qualification (PQ)
Validation is not a one-time event; it requires periodic requalification, adding to operational costs and potential downtime.
3. Utility and Cooling Costs
ULT freezers consume significant energy. A single -80°C freezer can use as much electricity as an average household, leading to thousands of dollars in annual electricity costs per unit. Additionally, HVAC systems must work harder to counteract the heat generated by multiple freezers, thereby increasing cooling capacity requirements and electricity costs.
4. External Monitoring and Security
Biosample storage requires 24/7 temperature monitoring to prevent loss. Implementing remote alarm systems, backup servers, and security redundancies adds substantial cost and complexity. Organizations must also invest in data logging solutions to maintain compliance with regulatory bodies. Additionally, there must be trained personnel available to respond to equipment alerts, even when such events occur at 2 a.m. on a Saturday morning.
5. Backup Power and Redundancy
Power failures pose a severe risk to biological samples. Ensuring continuity requires backup generators, uninterruptible power supplies (UPS), and failover protocols. These systems require ongoing testing, maintenance, and fuel reserves, adding to operational overhead.
6. Maintenance and Repairs
Even the most advanced freezers require routine maintenance, including filter changes, compressor replacements, and checks on seal integrity. Outside of regular maintenance, emergency repairs could result in unexpected downtime and create storage capacity issues.
7. Space Constraints and Expansion Limitations
Each ULT freezer occupies a significant footprint, requiring specialized lab space with reinforced flooring, climate control, and appropriate clearance. As storage demand increases, the facility may require costly renovations or even relocation to accommodate the additional space needed.
Outsourced Biostorage
In contrast, outsourcing biosample storage to a specialized facility like SciSafe offers advancements in off-site storage capabilities, biorepository technologies, and operating models provide biopharmaceutical companies with attractive alternatives to the in-house option.
1. Predictable, Scalable Costs
Instead of sinking capital into equipment purchases, outsourcing offers a predictable monthly or annual fee structure. This allows organizations to allocate resources more effectively, avoiding large upfront investments and unexpected repair expenses. Often, these costs can be treated as recurring expenses rather than capital investments and offer an accounting advantage in some instances.
2. Compliance and Validation Included
SciSafe’s facilities are GMP/cGMP-compliant and FDA-registered, meaning all necessary validation and regulatory requirements are handled by experts. Clients benefit from fully qualified GMP cold storage conditions without the hassle of maintaining their own validation processes.
3. Energy Efficiency and Sustainability
Dedicated biostorage warehouses are designed for optimal energy efficiency, using cutting-edge cooling and redundancy systems that reduce overall energy consumption compared to decentralized, in-house storage solutions.
4. Continuous Monitoring and Security
SciSafe provides 24/7/365 monitoring, real-time reporting, and comprehensive alarm systems that ensure sample integrity. Clients gain access to robust security protocols without the need to fund, staff, and maintain their own monitoring infrastructure.
5. Built-In Backup Power and Redundancy
Our facilities are equipped with industrial-grade backup power systems and comprehensive emergency response protocols. Unlike in-house storage, where power failures can be catastrophic, outsourced biosample storage ensures business continuity without additional investment.
6. No Maintenance Hassles
Storage providers handle all freezer maintenance, repairs, and emergency response measures, eliminating unexpected costs and downtime for clients.
7. Flexible, Scalable Storage Capacity
As research needs evolve, outsourced storage offers unmatched flexibility. SciSafe clients can scale up or down as needed without the burden of purchasing new freezers or modifying facility space.
Key Considerations When Deciding Between In-House Storage and Outsourcing
Organizations evaluating storage options should consider:
- Total Cost of Ownership vs. Predictable Expenses: Although the initial cost of freezers may seem manageable, factoring in ongoing utilities, maintenance, monitoring, and compliance shifts the financial equation in favor of outsourcing.
- Risk Management: Outsourcing mitigates the risks associated with power failures, equipment malfunctions, and regulatory non-compliance.
- Operational Focus: Maintaining in-house storage requires dedicated personnel and infrastructure. Outsourcing enables teams to concentrate on their core research and development efforts.
- Scalability: For organizations anticipating growth, outsourced biostorage provides a seamless expansion path without the logistical headaches of acquiring additional in-house capacity.
Outsource Your Biosample Storage
While in-house biorepository may seem like an attractive option, the true costs of equipment, validation, utilities, monitoring, backup power, maintenance, and space constraints can quickly outweigh the perceived benefits. SciSafe provides cost-effective, secure, and scalable solutions that ensure sample integrity while minimizing operational burdens.
For life sciences organizations looking to optimize costs and mitigate risks, outsourcing biostorage is not just a practical choice; it’s a strategic advantage.
Weighing your biopharma sample storage or cold chain logistics options? Let’s talk about how the experts at SciSafe can help you save time and money, and bring peace of mind.